NCT07693634 Tele-rehabilitation for Recreational Athletes With Patellofemoral Pain Syndrome
| NCT ID | NCT07693634 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Faisalabad |
| Condition | Patellofemoral Pain Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 26 participants |
| Start Date | 2026-06-09 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 26 participants in total. It began in 2026-06-09 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a randomized clinical trial designed to evaluate the usability and effectiveness of a tele-rehabilitation program in recreational athletes with Patellofemoral Pain Syndrome (PFPS). A total of 26 participants aged 18-35 years with unilateral PFPS will be randomly allocated into either a conventional physiotherapy group or a tele-rehabilitation group. Both groups will receive the same evidence-based exercise protocol comprising stretching, strengthening, balance, and functional exercises over a four-week period; however, the intervention group will perform the exercises remotely using the Physitrack mobile application with regular virtual supervision and progress monitoring, while the control group will receive face-to-face physiotherapy sessions. Primary outcome measures will include pain intensity assessed by the Numerical Pain Rating Scale (NPRS), knee range of motion measured using a universal goniometer, and quality of life evaluated using the Knee Injury and Osteoarthritis Outcome Score (KOOS). The usability and patient satisfaction of the tele-rehabilitation platform will be assessed using the Telehealth Usability Questionnaire (TUQ). The findings of this study will determine whether tele-rehabilitation is a feasible, user-friendly, and effective alternative to conventional physiotherapy for improving clinical outcomes and rehabilitation accessibility in recreational athletes with PFPS.
Eligibility Criteria
Inclusion Criteria: * Recreational athletes * age between 18 and 35 * Males and females * Unilateral Anterior knee pain between 3 to 6 on NPRS and retro patellar pain brought on by squatting, knee flexion, climbing, descending stairs, and extended sitting * At least one month of knee pain * Positive Apprehension test * Can access the internet and smart phone * Kujala questionnaire scale Exclusion Criteria: * Knee meniscus, ligament, and tendon injuries * Knee effusion * Dislocation of the patella, subluxation, and fractures * Recent Surgery or fracture of the affected knee * Neuromuscular, metabolic, and rheumatologic disorders. * Who does not sign the consent form?
Contact & Investigator
Dr Muhammad Ateeb Research Associate, PhD Public Health
STUDY CHAIR
Research Associate , The University of Faisalabad, Faisalabad 38000, Pakistan
Frequently Asked Questions
Who can join the NCT07693634 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Patellofemoral Pain Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07693634 currently recruiting?
Yes, NCT07693634 is actively recruiting participants. Contact the research team at noreenkiran.DPT@tuf.edu.pk for enrollment information.
Where is the NCT07693634 trial being conducted?
This trial is being conducted at Faisalābad, Pakistan.
Who is sponsoring the NCT07693634 clinical trial?
NCT07693634 is sponsored by University of Faisalabad. The principal investigator is Dr Muhammad Ateeb Research Associate, PhD Public Health at Research Associate , The University of Faisalabad, Faisalabad 38000, Pakistan. The trial plans to enroll 26 participants.